Brief Biography

Dr. Charron joined SickKids in 2005 as Head of Nuclear Medicine. He completed his residency at McGill and his fellowship at Harvard in 1988. He was Chief of Nuclear Medicine at the Children’s Hospital of Pittsburgh where he was involved in the creation and development of PET/CT. In 2000, he was Chief of Nuclear Medicine at the Children’s Hospital of Philadelphia and Associate Professor at PENN. Both research teams won numerous international awards. Dr. Charron is the editor of a book and involved in numerous publications. He is often invited to speak nationally and internationally. He served as President of the Paediatric Council for the Society of Nuclear Medicine. He is a reviewer of manuscripts and meeting abstracts for national and international scientific societies, organizes numerous courses, chairs scientific sessions and serves on several committees. Dr. Charron has been the recipient of grants, including NIH, and serves as Senior Associate Scientist at the Research Institute.

Education:

• MD, Resident, McGill University, Fellowship, Harvard University

Faculty Appointments:

• 1990-98: Assistant Professor of Diagnostic Radiology, University of Pittsburgh School of Medicine
• 1998-2000: Associate Professor of Diagnostic Radiology, University of Pittsburgh School of Medicine
• 2000-04: Associate Professor of Diagnostic Radiology, University of Pennsylvania School of Medicine
• 2001-05: Professor of Diagnostic Imaging, University of Toronto

Hospital and Administrative Appointments:

• 1990-2000:Attending Nuclear Physician, University of Pittsburgh Medical Center Pittsburgh, PA and VAMC
• 1992-2000:Attending Nuclear Physician, Children’s Hospital of Pittsburgh
• 1993-2000 Chief, Division of Nuclear Medicine, Children’s Hospital of Pittsburgh
• 1998-2000: Chief, Division of Nuclear Medicine, Tod’s Children’s Hospital, Youngstown, Ohio
• 2000-2004 Chief, Division Nuclear Medicine, Children’s Hospital of Philadelphia
• 2005-Chief, Division Nuclear Medicine, The Hospital for Sick Children
• 2005-Head of Research for Diagnostic Imaging, The Hospital for Sick Children
• 2005-2011 Senior Associate Scientist, Research Institute, The Hospital for Sick Children

Research Interests

Our current research involves nuclear medicine, positron emission tomography (PET) and therapeutic nuclear medicine.

Human milk fortifier (HMF) Study
Growth & development in preterm infants fed human milk containing a powdered human milk fortifier (HMF) post hospital discharge
Dr. Deborah L. O'Connor, Clinical Dietetics
EXA - Total body fat composition

Bone mineral densitometry (BMD) in neonates with bowel disease
Dr. Aideen Moore, Neonatology
Dual-energy x-ray absorptiometry (DEXA) - Total body fat composition

Steroid-induced osteoparosis in the paediatric population - Canadian incidence study (STOPP-CIS)
Dr. Ron Grant, Haematology / Oncology
DEXA-Total Body fat composition, L-spine & femur
(baseline study is clinical, the rest research)

Childhood asthma management program study - phase 2 (CAMPS/2)
Dr. P.J. Subbarao (originally Dr I. MacLusky), Respiratory Medicine
DEXA - L-spine

A cross-sectional study of overweight in paediatric survivors of acute lymphoid leukemia (ALL)
Dr. Paul Nathan, Haematology / Oncology
DEXA - Total body fat composition

PET-CT phantoms experiment
PMH UHN-PMH 00100 PD05-026 3/31/08

Publications

Coates AL, Green M, Leung K, Chan J, Ribeiro N, Louca E, Ratjen F, Charron M, Tservistas M, Keller M. Rapid pulmonary delivery of inhaled tobramycin for Pseudomonas infection in cystic fibrosis: a pilot project. Pediatr Pulmonol. 2008 Aug;43(8):753-9

Ribeiro N, Green M, Charron M. Assessment of multiple intravenous infusion pump systems infusing into a single site. J Nucl Med Technol 2008; 36(2): 88-90

Noli K, Solomon M, Charron M, Golding F, Ling SC. The prevalence of hepatopulmonary syndrome in children. Pediatrics. 2008;112:e498-e500.

Coates AL, Green M, Leung K, Louca E, Tservistas M, Chan J, Ribeiro N, Charron M. The challenges of quantitative measurement of lung deposition using 99mTc-DTPA from delivery systems with very different delivery times. J Aerosol Med 2007. 20(3): 320-330.

Chotipanich C, Rubin J, Lin J, Charron M. Clinical follow-up of children with low differential function on diuretic renogram. J Med Assoc Thai 2007. 90 (4): 754-61.

Chotipanich C, Hickeson M, Khan J, Beauchemin D, Canning D, Charron M. Correlation of the ERPF with the extraction fraction values of technetium-99m mercaptoacetyltriglycine. J Med Assoc Thai. J Med Assoc Thai. 2006 Sep;89(9):1479-86.

Hoe FM, Charron M, Moshang T Jr. Use of the recombinant human TSH stimulated thyroglobulin level and diagnostic whole body scan in children with differentiated thyroid carcinoma. J Pediatr Endocrinol Metab 2006; 19(1):25-30.

Messina JA, Cheng SC, Franc BL, Charron M, Shulkin B, To B, Maris JM, Yanik G, Hawkins RA, Matthay KK. Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma. Running Title: mIBG scoring in relapsed neuroblastoma. Pediatr Blood Cancer 2006; 47(7):865-874.

Bhargava P, Charron M, Beauchemin D. Asymmetric lower limb muscle activity on a gallium scan. Clin Nucl Med 2005; 30(5):367-368.

DuBois SG, Messina J, Maris JM, Huberty J, Glidden DV, Veatch J, Charron M, Hawkins R , Matthay KK. Hematologic toxicity of high dose 131I-metaiodobenzylguanidine therapy for advanced neuroblastoma. J Clin Oncol 2004; 22:2452-2460.